Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China flag China · Delayed Price · Currency is CNY
5.36
-0.07 (-1.29%)
Nov 18, 2026, 3:04 PM CST

SHE:000952 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
618.49612.31635.05730.11794.85785.1
Other Revenue
11.6711.673.757.712.790.47
630.16623.97638.8737.82797.64785.57
Revenue Growth
4.01%-2.32%-13.42%-7.50%1.54%14.15%
Cost of Revenue
496.91483.2524.77549.89510.22487.42
Gross Profit
133.25140.77114.03187.93287.42298.15
Selling, General & Admin
194.24228.16263.03194.83149.94137.29
Research & Development
32.541.9156.8274.7568.9852.06
Other Operating Expenses
26.2816.714.0312.9213.515.97
Operating Expenses
262.7294.05331.08282.64236.3210.87
Operating Income
-129.45-153.28-217.04-94.751.1387.28
Interest Expense
-45.64-51.16-61.98-49.15-21.1-16.71
Interest & Investment Income
0.5819.412.063.468.3121.95
Currency Exchange Gain (Loss)
-0.16-0.164.312.074.33-2.11
Other Non Operating Income (Expenses)
-5.78-2.81-0.38-0.04-1.017.3
EBT Excluding Unusual Items
-180.46-188-273.03-138.3641.6597.72
Gain (Loss) on Sale of Investments
-0.78--27.92-10.02--
Gain (Loss) on Sale of Assets
27.70.55-2.40.25-4.310.54
Asset Writedown
-259.39-265.29-30.68-0.12-0.14-0.01
Legal Settlements
--1.040.9-0.755.55
Other Unusual Items
14.039.6412.716.6923.6320.54
Pretax Income
-398.9-443.1-320.29-140.6760.08124.34
Income Tax Expense
-1.34-4.16-5.1611.7512.418.53
Earnings From Continuing Operations
-397.56-438.95-315.13-152.4147.68105.81
Minority Interest in Earnings
30.4634.4519.8412.172.654.3
Net Income
-367.1-404.49-295.29-140.2550.33110.11
Net Income to Common
-367.1-404.49-295.29-140.2550.33110.11
Net Income Growth
-----54.29%47.50%
Shares Outstanding (Basic)
346348352354351344
Shares Outstanding (Diluted)
346348352354353344
Shares Change
-0.87%-1.01%-0.60%0.36%2.54%2.85%
EPS (Basic)
-1.06-1.16-0.84-0.400.140.32
EPS (Diluted)
-1.06-1.16-0.84-0.400.140.32
EPS Growth
-----55.42%43.41%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
11624.79-154.28-715.1-158.63-20.7
Free Cash Flow Per Share
0.340.07-0.44-2.02-0.45-0.06
Dividend Per Share
-----0.060
Dividend Growth
-----0%
Gross Margin
21.14%22.56%17.85%25.47%36.03%37.95%
Operating Margin
-20.54%-24.57%-33.98%-12.83%6.41%11.11%
Profit Margin
-58.26%-64.83%-46.23%-19.01%6.31%14.02%
Free Cash Flow Margin
18.41%3.97%-24.15%-96.92%-19.89%-2.63%
EBITDA
26.766.35-52.8424.04148.58178.15
EBITDA Margin
4.25%1.02%-8.27%3.26%18.63%22.68%
D&A For EBITDA
156.21159.63164.2118.7597.4590.87
EBIT
-129.45-153.28-217.04-94.751.1387.28
EBIT Margin
-20.54%-24.57%-33.98%-12.83%6.41%11.11%
Effective Tax Rate
----20.64%14.90%
Revenue as Reported
630.16623.97638.8737.82797.64785.57
Advertising Expenses
-2.5115.889.055.846.12